Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cortex (Cor) [formerly CORX] -- Ignore unavailable to you. Want to Upgrade?

To: Michael Olin who wrote (562)	10/19/1998 9:18:00 AM
From: RBlatch	Read Replies (3) \| Respond to of 1255

Michael - I think more then a handful of us longs out here. We just don't say much because there hasn't been much news lately. Waiting is the hardest part of this game. But if you hit the right stock, the rewards are astronomical. Cordially, RBlatch

To: Michael Olin who wrote (562)	10/19/1998 2:52:00 PM
From: NeuroInvestment	Read Replies (1) \| Respond to of 1255

Cortex does have a history of media-spurred blips, though your list is a bit inaccurate: 1) In November 1996 the stock shot over 7 after Gary Lynch gave a very charismatic press presentation at the Society for Neuroscience annual meeting. 2) There was a modest response to an ABC News story on Ampakines in February 1997. I was the technical consultant on the piece. The content consisted of videos of rats who were performing well on a maze test due to CX516, and interviews with enthused researchers about the rat studies and the human need. 3) Last May Cortex went up to 3.5 in sympathy with NeoTherapeutics, which is in Phase II Alzheimer's trials with its lead compound, after a press story went out on NEOT and overblown comments about the effects of its drug in humans. It has never been clear to me why CORX went up on NEOT's coattails--though some may confuse the two companies, the Canadian trials referred to by a poster on this thread were in fact NEOT's. 4) Since the NBC story was remarkably similar to the ABC piece of 20 months ago, made no mention of the human trials that have been done (some completed) between 1995 and the present time, and given the above history of CORX's brief price blips, it is perhaps not that surprising that this time, the market reacted with a yawn. NeuroInvestment (www.neuroinv.com)